|
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
Description
(Resistance to Targeted Anti-Cancer Therapeutics (15)) 1st ed. 2018 Edition
by Yosef Yarden (Editor), Moshe Elkabets (Editor)
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.
Details
Year:
2018
Pages:
225
Language:
English
Format:
PDF
Size:
5 MB
ISBN-10:
3030098176, 3319679309
ISBN-13:
978-3030098179, 978-3319679303
ASIN:
B07BS2TY5G
Share this product
You might also be interested in one of these books
|
KETAB DOWNLOAD
Druggable Lipid Signaling Pathways
|
KETAB DOWNLOAD
Chemotherapy for Leukemia: Novel Drugs and Treatment
|
KETAB DOWNLOAD
Biomarkers in Cancer Therapy: Liquid Biopsy Comes of Age
|
KETAB DOWNLOAD
Novel Therapeutics for Rare Lymphomas
|
KETAB DOWNLOAD
Epigenetic Cancer Therapy